{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:13:29Z","timestamp":1792898009936,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bbr.2023.114561","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:30:13Z","timestamp":1688124613000},"page":"114561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dyclonine relieves the Parkinson\u2019s disease progression in rotenone-induced Drosophila model"],"prefix":"10.1016","volume":"452","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.bbr.2023.114561_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bbr.2023.114561_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"9680","key":"10.1016\/j.bbr.2023.114561_bib3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bbr.2023.114561_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bbr.2023.114561_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archderm.1955.01540300050013","article-title":"Evaluation of a new topical anesthetic, dyclonine hydrochloride","volume":"71","author":"Shelmire","year":"1955","journal-title":"AMA Arch. Derm."},{"issue":"6","key":"10.1016\/j.bbr.2023.114561_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/00325481.1956.11708352","article-title":"Dyclonine hydrochloride: a new topical antipruritic agent","volume":"19","author":"Morginson","year":"1956","journal-title":"Post. Med."},{"issue":"2","key":"10.1016\/j.bbr.2023.114561_bib7","doi-asserted-by":"crossref","first-page":"eaaw8702","DOI":"10.1126\/sciadv.aaw8702","article-title":"Neuron-based high-content assay and screen for CNS active mitotherapeutics","volume":"6","author":"Varkuti","year":"2020","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.bbr.2023.114561_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116297","article-title":"Neuroinflammation in Friedreich's Ataxia","volume":"23","author":"Apolloni","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.bbr.2023.114561_bib9","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1093\/hmg\/ddu408","article-title":"Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia","volume":"23","author":"Sahdeo","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.bbr.2023.114561_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101211","article-title":"The role of Nrf2 in neural stem\/progenitors cells: from maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease","volume":"65","author":"Kahroba","year":"2021","journal-title":"Ageing Res Rev."},{"issue":"11","key":"10.1016\/j.bbr.2023.114561_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An Overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2023.114561_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2007.01.131","article-title":"Nrf2-mediated protection against 6-hydroxydopamine","volume":"1144","author":"Jakel","year":"2007","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.bbr.2023.114561_bib13","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2023.114561_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev.neuro.26.041002.131425","article-title":"Human neurodegenerative disease modeling using Drosophila","volume":"26","author":"Bonini","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2023.114561_bib15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1101\/gr.169101","article-title":"A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster","volume":"11","author":"Reiter","year":"2001","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.bbr.2023.114561_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1871527320666210809120621","article-title":"Drosophila: a model to study the pathogenesis of Parkinson's disease","volume":"21","author":"Rahul","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"48","key":"10.1016\/j.bbr.2023.114561_bib17","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","article-title":"Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster","volume":"24","author":"Coulom","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2023.114561_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137187","article-title":"Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster","volume":"805","author":"Li","year":"2023","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bbr.2023.114561_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-018-1278-2","article-title":"Inhibition of NF-kappaB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons","volume":"15","author":"Li","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2023.114561_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12881-014-0131-4","article-title":"Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study","volume":"15","author":"von Otter","year":"2014","journal-title":"BMC Med. Genet"},{"issue":"1","key":"10.1016\/j.bbr.2023.114561_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00441-004-0937-z","article-title":"Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration","volume":"318","author":"Uversky","year":"2004","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.bbr.2023.114561_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"issue":"s1","key":"10.1016\/j.bbr.2023.114561_bib23","first-page":"S3","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"issue":"9","key":"10.1016\/j.bbr.2023.114561_bib24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson's disease: a special essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114561_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuro.2013.04.006","article-title":"Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster","volume":"37","author":"Sudati","year":"2013","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.bbr.2023.114561_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1139\/cjpp-2017-0207","article-title":"Protective effect of (-)-alpha-bisabolol on rotenone-induced toxicity in Drosophila melanogaster","volume":"96","author":"Leite","year":"2018","journal-title":"Can. J. Physiol. Pharm."},{"issue":"2","key":"10.1016\/j.bbr.2023.114561_bib27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuropharm.2006.09.003","article-title":"Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats","volume":"52","author":"Sanchez-Reus","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114561_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.09.015","article-title":"Alpha-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease","volume":"192","author":"A","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbr.2023.114561_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040589","article-title":"Heme Oxygenase-1 signaling and redox homeostasis in physiopathological conditions","volume":"11","author":"Consoli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbr.2023.114561_bib30","article-title":"Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson's disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.bbr.2023.114561_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15698\/mic2016.02.476","article-title":"Inhibition of Abeta(42) oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs","volume":"3","author":"Park","year":"2016","journal-title":"Micro Cell"},{"issue":"5","key":"10.1016\/j.bbr.2023.114561_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00000542-195609000-00002","article-title":"Dyclonine; a new local anesthetic agent: clinical evaluation","volume":"17","author":"Greifenstein","year":"1956","journal-title":"Anesthesiology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823002796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823002796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:44:42Z","timestamp":1759067082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"alternative-id":["S0166432823002796"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114561","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyclonine relieves the Parkinson\u2019s disease progression in rotenone-induced Drosophila model","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114561"}}